|
2024
|
G/S
|
Financial services, namely, financing related to intellectual property portfolios; financial serv... |
|
|
G/S
|
Financial services, namely, financing related to
intellectual property portfolios; financial ser... |
|
|
G/S
|
Financial services, namely, financing services related to intellectual property portfolios; Finan... |
|
2023
|
Invention
|
Parathyroid hormone receptor 1(pth1r) antibodies and uses thereof.
The present disclosure relate... |
|
|
Invention
|
Formulations for anti-insulin receptor antibody and uses thereof. The present disclosure relates,... |
|
|
Invention
|
Formulations for anti-insulin receptor antibody and uses thereof |
|
2022
|
Invention
|
Compositions and methods for delaying the incidence of labor.
The invention provides composition... |
|
|
Invention
|
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal pol... |
|
|
Invention
|
Novel modulators.
Antibodies that modulate insulin receptor signaling are provided. |
|
2021
|
Invention
|
Compositions and methods for the treatment or prevention of preterm labor.
The disclosure provid... |
|
|
Invention
|
Compositions and methods for the treatment or prevention of preterm labor. The disclosure provide... |
|
2020
|
Invention
|
Antibodies that bind interleukin-2 and uses thereof. The present disclosure relates, in general, ... |
|
|
Invention
|
Methods for the treatment of gout.
Disclosed are methods for the treatment and/or prevention of ... |
|
|
Invention
|
Cardiovascular related uses of il-1beta antibodies and binding fragments thereof.
Disclosed are ... |
|
2019
|
Invention
|
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof. The present disclosure relate... |
|
|
G/S
|
Financing related to intellectual property portfolios; financing of pharmaceutical, drug, and med... |
|
|
G/S
|
Financing of pharmaceutical, drug, and medical device development |
|
|
Invention
|
Compositions and methods for delaying the incidence of labor. The invention provides compositions... |
|
2018
|
G/S
|
Licensing of technology in the field of pharmaceuticals, medicine, chemicals, and biotechnology; ... |
|
|
G/S
|
Licensing of technology in the field of pharmaceuticals, medicine, chemicals,and biotechnology; l... |
|
|
Invention
|
Modulators. Antibodies that modulate insulin receptor signaling are provided. |
|
|
Invention
|
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia.
The pres... |
|
2017
|
Invention
|
Cardiovascular related uses of il-1β antibodies and binding fragments thereof. Disclosed are meth... |
|
2016
|
Invention
|
Substituted pyrimidines for inhibiting raf kinase activity. The present invention provides method... |
|
|
Invention
|
Flexible manufacturing system. A flexible, multi-product, multi-technology, expandable facility f... |
|
|
Invention
|
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia. The prese... |
|
|
Invention
|
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery. The present... |
|
2014
|
Invention
|
Substituted 1,3-thiazoles as synthetic intermediates for preparation of raf kinase inhibitors. Th... |
|
2013
|
Invention
|
Antibodies specific for fgfr4 and methods of use. The present disclosure provides methods and com... |
|
|
Invention
|
Methods for the treatment of il-1β related diseases. Disclosed are methods for the treatment and/... |
|
|
Invention
|
Methods for the treatment of uveitis with il-1β binding antibodies. Disclosed are methods and mat... |
|
|
Invention
|
Methods for improvement of beta cell function.
Disclosed are methods for improvement of beta cel... |
|
|
Invention
|
Pharmaceutical compositions comprising il-1b binding antibodies and fragments thereof. An IL-1β b... |
|
2012
|
Invention
|
Methods for treating acne.
The present disclosure relates to methods and materials for treating ... |
|
|
Invention
|
Compounds useful as raf kinase inhibitors. The present invention provides compounds useful as inh... |
|
2011
|
Invention
|
Method of treating inflammatory eye disease with il-1β binding antibodies. An IL-1β binding antib... |
|
|
Invention
|
Methods for the treatment of il-1β related conditions. Disclosed are methods and materials for in... |
|
|
Invention
|
Methods for the treatment of il-1.beta. related conditions. Disclosed are methods and materials f... |
|
2010
|
Invention
|
Insulin receptor binding antibodies. Antibodies that modulate insulin receptor signaling are prov... |
|
2009
|
Invention
|
Methods for treating il-1β related diseases by administering an anti-il-1β antibody. Disclosed ar... |
|
|
Invention
|
Methods for improvement of beta cell function with anti-il-1β antibodies or fragments thereof. Di... |
|
|
Invention
|
Methods for the treatment of rheumatoid arthritis.
Disclosed are compositions and methods for th... |
|
1983
|
G/S
|
Monoclonal antibodies, derivatives of monoclonal antibodies, purified toxins and their fragments,... |
